Cargando…

Reduction of complement factor H binding to CLL cells improves the induction of rituximab-mediated complement-dependent cytotoxicity

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Hörl, S, Bánki, Z, Huber, G, Ejaz, A, Windisch, D, Muellauer, B, Willenbacher, E, Steurer, M, Stoiber, H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027870/ http://dx.doi.org/10.1038/leu.2013.230

Ejemplares similares

Reduction of complement factor H binding to CLL cells improves the induction of rituximab-mediated complement-dependent cytotoxicity
por: Hörl, S, et al.
Publicado: (2013)

Complement as an Endogenous Adjuvant for Dendritic Cell-Mediated Induction of Retrovirus-Specific CTLs
por: Bánki, Zoltán, et al.
Publicado: (2010)

Novel Bifunctional Single-Chain Variable Antibody Fragments to Enhance Virolysis by Complement: Generation and Proof-of-Concept
por: Huber, Georg, et al.
Publicado: (2014)

Interference of the Zika Virus E-Protein With the Membrane Attack Complex of the Complement System
por: Malekshahi, Zahra, et al.
Publicado: (2020)

Erratum to: aHUS caused by complement dysregulation: new therapies on the horizon
por: Waters, Aoife M., et al.
Publicado: (2012)

Lack of adalimumab's complement dependent cytotoxicity on human cells expressing complement regulatory proteins
por: Grebe, K M, et al.
Publicado: (2010)

Incorporation of CD55 into the Zika Viral Envelope Contributes to Its Stability against Human Complement
por: Malekshahi, Zahra, et al.
Publicado: (2021)

Gemcitabine enhances rituximab‐mediated complement‐dependent cytotoxicity to B cell lymphoma by CD20 upregulation
por: Hayashi, Kazumi, et al.
Publicado: (2016)

Erratum to: Plasma complement factor H is associated with disease activity of patients with ANCA-associated vasculitis
por: Chen, Su-Fang, et al.
Publicado: (2017)

Erratum in: Genetic Variability of Complement Factor H Has Ethnicity-Specific Associations With Choroidal Thickness
Publicado: (2023)

Editorial: The Role of Complement in Microbial Infections
por: Stoiber, Heribert, et al.
Publicado: (2021)

Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study
por: Egle, Alexander, et al.
Publicado: (2018)

Bispecific mAb(2) Antibodies Targeting CD59 Enhance the Complement-Dependent Cytotoxicity Mediated by Rituximab
por: Stadlbauer, Katharina, et al.
Publicado: (2022)

Exploring complement-dependent cytotoxicity by rituximab isotypes in 2D and 3D-cultured B-cell lymphoma
por: Lara, Sandra, et al.
Publicado: (2022)

EVIDENCE FOR LINKAGE BETWEEN HL-A HISTOCOMPATIBILITY GENES AND THOSE INVOLVED IN THE SYNTHESIS OF THE SECOND COMPONENT OF COMPLEMENT
por: Fu, S. M., et al.
Publicado: (1974)

INTRARENAL COMPLEMENT FIXATION BY CYTOTOXIC ANTIBODIES
por: Sellin, D., et al.
Publicado: (1970)

Targeting Viral Antigens to CD11c on Dendritic Cells Induces Retrovirus-Specific T Cell Responses
por: Ejaz, Asim, et al.
Publicado: (2012)

Xenoantigen-Dependent Complement-Mediated Neutralization of Lymphocytic Choriomeningitis Virus Glycoprotein-Pseudotyped Vesicular Stomatitis Virus in Human Serum
por: Pipperger, Lisa, et al.
Publicado: (2019)

Active Human Complement Reduces the Zika Virus Load via Formation of the Membrane-Attack Complex
por: Schiela, Britta, et al.
Publicado: (2018)

Effects of complement and serum IgG on rituximab-dependent natural killer cell-mediated cytotoxicity against Raji cells
por: Li, Yang, et al.
Publicado: (2019)

THE COMPLEMENT BINDING TEST IN RABIES
por: Berry, Jane L.
Publicado: (1910)

Erratum to: Charged residues next to transmembrane regions revisited: “Positive-inside rule” is complemented by the “negative inside depletion/outside enrichment rule”
por: Baker, James Alexander, et al.
Publicado: (2017)

Erratum to: Practice-derived data on Non-vitamin K antagonist Oral Anticoagulant (NOAC) therapy to complement observations from randomized trials
Publicado: (2020)

Sorafenib improves rituximab and ofatumumab efficacy by decreasing the expression of complement regulatory proteins
por: Dwojak, M, et al.
Publicado: (2015)

Monitoring of the Complement System Status in Patients With B-Cell Malignancies Treated With Rituximab
por: Felberg, Anna, et al.
Publicado: (2020)

Erratum for Densi et al., “Synonymous and Nonsynonymous Substitutions in Dictyostelium discoideum Ammonium Transporter amtA Are Necessary for Functional Complementation in Saccharomyces cerevisiae”
por: Densi, Asha, et al.
Publicado: (2023)

Complement in Human Disease
por: Flierl, Michael A., et al.
Publicado: (2013)

Rituximab in two cases of Goodpasture's syndrome
por: Schless, Birgit, et al.
Publicado: (2009)

A CD21 low phenotype, with no evidence of autoantibodies to complement proteins, is consistent with a poor prognosis in CLL
por: Nichols, Eva-Maria, et al.
Publicado: (2015)

Rituximab maintenance overcomes the negative prognostic factor of obesity in CLL: Subgroup analysis of the international randomized AGMT CLL‐8a mabtenance trial
por: Egle, Alexander, et al.
Publicado: (2019)

Excision repair cross-complementing group 1 (ERCC1) overexpression inhibits cell apoptosis and is associated with unfavorable prognosis of esophageal squamous cell carcinoma: Erratum
Publicado: (2018)

Role of Complement in Multiorgan Failure
por: Rittirsch, Daniel, et al.
Publicado: (2012)

Update on the role of venetoclax and rituximab in the treatment of relapsed or refractory CLL
por: D’Rozario, James, et al.
Publicado: (2019)

Complement receptor is an inhibitor of the complement cascade
Publicado: (1981)

Complement supports progression of HIV and turns neutralising antibodies at low concentration into infection enhancing antibodies
por: Dierich, Manfred P, et al.
Publicado: (2006)

Complementing clinical cancer registry data with patient reported outcomes: A feasibility study on routine electronic patient‐reported outcome assessment for the Austrian Myelome Registry
por: Sztankay, Monika, et al.
Publicado: (2019)

Complement
por: Treffers, Henry P.
Publicado: (1966)

THE STRUCTURAL BASIS FOR BINDING OF COMPLEMENT BY IMMUNOGLOBULIN M
por: Hurst, Mary M., et al.
Publicado: (1974)

MOGAD patient autoantibodies induce complement, phagocytosis, and cellular cytotoxicity
por: Yandamuri, Soumya S., et al.
Publicado: (2023)

Complement and Complement Targeting Therapies in Glomerular Diseases
por: Andrighetto, Sofia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4j2i0bivvlo3lrj64jh4iiko1g